Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Strong Support from the DanCann Pharma Board of Directors, who convert their warrants into shares and buy more than 80,000 shares equaling DKK +400,000
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Strong Support from the DanCann Pharma Board of Directors, who convert their warrants into shares and buy more than 80,000 shares equaling DKK +400,000
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S Announces Exercise of Warrants for Proceeds of DKK approx. DKK 9.3 million to Strengthen the Financial Position
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: EUROPEAN UNION INTELLECTUAL PROPERTY OFFICE CERTIFICATE OF REGISTRATION for product portfolio trademarks
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Morten Martinsen, COO, sells minor position of shares in DanCann Pharma
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Germanys intention to legalize cannabis is a gamechanger for Europe
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: CEO, Jeppe Krog Rasmussen (Xignotus Capital ApS), locks his position in DanCann Pharma for 3 years - and thereby more than 21% of the total share capital
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: It's official: A permanent scheme for medical cannabis in Denmark
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials of QIXLEEF™
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S publishes Q3-2021 report